115 related articles for article (PubMed ID: 24337954)
21. Novel therapies for renal cell carcinoma.
Fishman M; Seigne J; Antonia S
Expert Opin Investig Drugs; 2001 Jun; 10(6):1033-44. PubMed ID: 11772233
[TBL] [Abstract][Full Text] [Related]
22. Genomics of renal cell cancer: the biology behind and the therapy ahead.
Jones J; Libermann TA
Clin Cancer Res; 2007 Jan; 13(2 Pt 2):685s-692s. PubMed ID: 17255294
[TBL] [Abstract][Full Text] [Related]
23. MET Expression in Primary and Metastatic Clear Cell Renal Cell Carcinoma: Implications of Correlative Biomarker Assessment to MET Pathway Inhibitors.
Shuch B; Falbo R; Parisi F; Adeniran A; Kluger Y; Kluger HM; Jilaveanu LB
Biomed Res Int; 2015; 2015():192406. PubMed ID: 26448928
[TBL] [Abstract][Full Text] [Related]
24. [Intratumoral heterogeneity in renal cell carcinoma. Molecular basis and translational implications].
Höfflin R; Roth W; Sültmann H; Grüllich C; Hatiboglu G; Nyarangi-Dix J; Schönberg G; Teber D; Hadaschik B; Pahernik S; Hohenfellner M; Duensing S
Urologe A; 2015 Jun; 54(6):800-3. PubMed ID: 25758237
[TBL] [Abstract][Full Text] [Related]
25. What can molecular pathology contribute to the management of renal cell carcinoma?
Stewart GD; O'Mahony FC; Powles T; Riddick AC; Harrison DJ; Faratian D
Nat Rev Urol; 2011 May; 8(5):255-65. PubMed ID: 21487387
[TBL] [Abstract][Full Text] [Related]
26. From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma.
Arsanious A; Bjarnason GA; Yousef GM
Mol Cancer; 2009 Mar; 8():20. PubMed ID: 19291329
[TBL] [Abstract][Full Text] [Related]
27. Renal cell carcinoma: where will the state-of-the-art lead us?
Brannon AR; Rathmell WK
Curr Oncol Rep; 2010 May; 12(3):193-201. PubMed ID: 20425079
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic Strategies for Hereditary Kidney Cancer.
Sidana A; Srinivasan R
Curr Oncol Rep; 2016 Aug; 18(8):50. PubMed ID: 27325049
[TBL] [Abstract][Full Text] [Related]
29. Update on targeted therapies for clear cell renal cell carcinoma.
Singer EA; Gupta GN; Srinivasan R
Curr Opin Oncol; 2011 May; 23(3):283-9. PubMed ID: 21330923
[TBL] [Abstract][Full Text] [Related]
30. Recent updates in renal cell carcinoma.
Rathmell WK; Godley PA
Curr Opin Oncol; 2010 May; 22(3):250-6. PubMed ID: 20154618
[TBL] [Abstract][Full Text] [Related]
31. Update on the biology and management of renal cell carcinoma.
Dutcher JP
J Investig Med; 2019 Jan; 67(1):1-10. PubMed ID: 30455223
[TBL] [Abstract][Full Text] [Related]
32. Biomarkers and new therapeutic targets in renal cell carcinoma.
Di Pietro G; Luu HN; Spiess PE; Sexton W; Dickinson S; Parker A; Park JY
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5874-5891. PubMed ID: 30280768
[TBL] [Abstract][Full Text] [Related]
33. Non-clear cell renal cell carcinoma: how new biological insight may lead to new therapeutic modalities.
Bex A; Larkin J; Blank C
Curr Oncol Rep; 2011 Jun; 13(3):240-8. PubMed ID: 21298371
[TBL] [Abstract][Full Text] [Related]
34. Basic science and research in renal cell carcinoma: from workbench to bedside.
Heidenreich A; Schrader AJ; Varga Z
Curr Opin Urol; 2003 Nov; 13(6):457-62. PubMed ID: 14560138
[TBL] [Abstract][Full Text] [Related]
35. Pediatric and young adult renal cell carcinoma.
Ray S; Jones R; Pritchard-Jones K; Dzhuma K; van den Heuvel-Eibrink M; Tytgat G; van der Beek J; Oades G; Murphy D
Pediatr Blood Cancer; 2020 Nov; 67(11):e28675. PubMed ID: 32869954
[TBL] [Abstract][Full Text] [Related]
36. Complexity of the genomic landscape of renal cell carcinoma: Implications for targeted therapy and precision immuno-oncology.
Sanfrancesco JM; Cheng L
Crit Rev Oncol Hematol; 2017 Nov; 119():23-28. PubMed ID: 29065981
[TBL] [Abstract][Full Text] [Related]
37. Intramedullary Spinal Metastatic Renal Cell Carcinoma: Systematic Review of Disease Presentation, Treatment, and Prognosis with Case Illustration.
Barrie U; Elguindy M; Pernik M; Adeyemo E; Aoun SG; Hall K; Reyes VP; El Ahmadieh TY; Bagley CA
World Neurosurg; 2020 Feb; 134():584-593. PubMed ID: 31734421
[TBL] [Abstract][Full Text] [Related]
38. An interdisciplinary consensus on the management of bone metastases from renal cell carcinoma.
Grünwald V; Eberhardt B; Bex A; Flörcken A; Gauler T; Derlin T; Panzica M; Dürr HR; Grötz KA; Giles RH; von Falck C; Graser A; Muacevic A; Staehler M
Nat Rev Urol; 2018 Aug; 15(8):511-521. PubMed ID: 29904105
[TBL] [Abstract][Full Text] [Related]
39. [Tumor profiling of renal cell tumors: relevance for diagnostics and therapy].
Junker K; Steiner T; Sanjmyatav J; Pilchowski R; Heinze C; Walter M; Schubert J
Pathologe; 2009 Mar; 30(2):105-10. PubMed ID: 19089427
[TBL] [Abstract][Full Text] [Related]
40. On-treatment biomarkers in metastatic renal cell carcinoma: towards individualization of prognosis?
Donskov F; Heng DY; Rini BI
Expert Rev Anticancer Ther; 2017 Feb; 17(2):97-99. PubMed ID: 27927054
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
